Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Timing matters in budgeting. This section outlines indicators for when to revisit and tweak your budget to reflect new expenses.
18,658 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
The POWI 2026 earnings transcript sheds light on how the company performed in Q1 and what the path ahead could look l...
Could Micron Technology stock realistically reach $1,500 within a year? This comprehensive analysis weighs AI-driven ...
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
A new wave in energy investing centers on nuclear power having moment. This article identifies three stocks that stan...
A Michigan retiree moving to Sarasota learns the hard truth: Medicare Advantage plans are local. The move triggers en...
Semiconductors took the spotlight as Micron sparked a broader tech rally. TheNasdaq led gains while the S&P 500 and D...
As the renewables wave grows, Clearway Energy (CWEN) stands out with a diversified solar and wind portfolio. This gui...
A major hedge fund recently disclosed a new stake in BORR, signaling a strategic bet in the offshore drilling sector....
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...